Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in …
K Kurose, E Sugiyama, Y Saito - Drug metabolism and …, 2012 - jstage.jst.go.jp
Drug lag, recently discussed extensively in Japan, can be divided into two phases: clinical
development time and application review time. The former factor is still an important problem …
development time and application review time. The former factor is still an important problem …
Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing
J Grzegorzewski, F Bartsch, A Köller… - Frontiers in …, 2022 - frontiersin.org
Caffeine is by far the most ubiquitous psychostimulant worldwide found in tea, coffee, cocoa,
energy drinks, and many other beverages and food. Caffeine is almost exclusively …
energy drinks, and many other beverages and food. Caffeine is almost exclusively …
Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk
The polymorphic P450 (CYP) enzyme superfamily is the most important system involved in
the biotransformation of many endogenous and exogenous substances including drugs …
the biotransformation of many endogenous and exogenous substances including drugs …
Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations
A LLerena, MEG Naranjo… - Expert opinion on …, 2014 - Taylor & Francis
Introduction: The frequency of CYP2D6 alleles, related to either a lack of or increased
enzymatic activity, which may lead to poor metabolism (PM) or ultrarapid metabolism (UM) …
enzymatic activity, which may lead to poor metabolism (PM) or ultrarapid metabolism (UM) …
Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization
J Kevin Hicks, JJ Swen, A Gaedigk - Current drug metabolism, 2014 - ingentaconnect.com
The cytochrome P450 2D6 (CYP2D6) enzyme contributes to the metabolism and/or
bioactivation of approximately 25% of clinically used drugs. The CYP2D6 gene locus is …
bioactivation of approximately 25% of clinically used drugs. The CYP2D6 gene locus is …
Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications
F Zhang, J Finkelstein - Pharmacogenomics and personalized …, 2019 - Taylor & Francis
Introduction Racial and ethnic categories are frequently used in pharmacogenetics literature
to stratify patients; however, these categories can be inconsistent across different studies. To …
to stratify patients; however, these categories can be inconsistent across different studies. To …
Genetic polymorphisms of drug‐metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population
K Arvanitidis, G Ragia, M Iordanidou… - Fundamental & …, 2007 - Wiley Online Library
The aim of the present study was to determine the prevalence of the most common allelic
variants of the polymorphic cytochrome P450 (CYP) enzymes CYP2D6, CYP2C9, CYP2C19 …
variants of the polymorphic cytochrome P450 (CYP) enzymes CYP2D6, CYP2C9, CYP2C19 …
Pharmacogenetics and forensic toxicology: A new step towards a multidisciplinary approach
N Di Nunno, M Esposito, A Argo, M Salerno, F Sessa - Toxics, 2021 - mdpi.com
Pharmacogenetics analyzes the individual behavior of DNA genes after the administration of
a drug. Pharmacogenetic research has been implemented in recent years thanks to the …
a drug. Pharmacogenetic research has been implemented in recent years thanks to the …
Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugs
T Hirota, S Eguchi, I Ieiri - Drug metabolism and pharmacokinetics, 2013 - jstage.jst.go.jp
Human cytochrome P450 (CYP) is a superfamily of hemoproteins which oxidize a number of
endogenous compounds and xenobiotics. The human CYP2C subfamily consists of four …
endogenous compounds and xenobiotics. The human CYP2C subfamily consists of four …
The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance
J Rosemary, C Adithan - Current clinical pharmacology, 2007 - ingentaconnect.com
CYP2C9 and CYP2C19 are important drug metabolizing enzymes and together metabolize
about 18% of currently available drugs. Some of the important groups of drugs that are …
about 18% of currently available drugs. Some of the important groups of drugs that are …